|31.36||+0.01 / +0.03%|
As of 4:14pm ET
|31.36||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 47.00 and a low estimate of 35.00. The median estimate represents a +30.74% increase from the last price of 31.36.
The current consensus among 6 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.